Company news
Hemostemix Inc news in 2024
Hemostemix Inc's news releases, calls and decks from 2024, newest first.
Hemostemix's Social Media Awareness of "Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
December 31, 2024
Hemostemix Drives Social Media Awareness of Its Regenerative Medicine Treatments
December 17, 2024
Hemostemix Announces $2,725,982 Update to Second Closing
December 3, 2024
Hemostemix Announces $2,675,981 Private Placement Including Second Tranche of $833,258
November 28, 2024
Hemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign Underway
November 25, 2024
Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement
October 31, 2024
Hemostemix's Private Placement
October 11, 2024
Hemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01
August 1, 2024
Hemostemix Announces Trademark Granted by Switzerland and Interest Payment
June 11, 2024
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments
June 3, 2024
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.
March 7, 2024
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences
February 6, 2024